BRD4 and gastric adenocarcinoma: Li et al. demonstrated that BRD4 acts as a transcriptional regulator of MAGI2-AS3, promoting the epithelial-mesenchymal transition (EMT) of MAGI2-AS3, which in turn promotes the invasion and metastasis of STAD [29].